相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The largest prospective warfarin-treated cohort supports genetic forecasting
Mia Wadelius et al.
BLOOD (2009)
A genome-wide association study of acenocoumarol maintenance dosage
Martina Teichert et al.
HUMAN MOLECULAR GENETICS (2009)
A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
Fumihiko Takeuchi et al.
PLOS GENETICS (2009)
CYP4F2 genetic variant alters required warfarin dose
Michael D. Caldwell et al.
BLOOD (2008)
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
Gregory M. Cooper et al.
BLOOD (2008)
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
B. F. Gage et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
WGAViewer: Software for genomic annotation of whole genome association studies
Dongliang Ge et al.
GENOME RESEARCH (2008)
Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients
P. A. Lenzini et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? Yes
S. M. Thacker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans
Nita A. Limdi et al.
PHARMACOGENOMICS (2008)
Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans
Nita A. Limdi et al.
PHARMACOGENOMICS (2008)
Enhanced functional recombinant factor VII production by HEK 293 cells stably transfected with VKORC1 where the gamma-carboxylase inhibitor calumenin is stably suppressed by shRNA transfection
Nadeem Wajih et al.
THROMBOSIS RESEARCH (2008)
Factors influencing warfarin dose requirements in African-Americans
Kathryn M. Momary et al.
PHARMACOGENOMICS (2007)
Population genomics of human gene expression
Barbara E. Stranger et al.
NATURE GENETICS (2007)
The genetic interaction between VKORC1 c1173t and calumenin a29809g modulates the anticoagulant response of acenocoumarol
R. Gonzalez-Conejero et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Warfarin response and vitamin K epoxide reductase complex 1 in African Americans and Caucasians
H. Schelleman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Relative impact of nucleotide and copy number variation on gene expression phenotypes
Barbara E. Stranger et al.
SCIENCE (2007)
Association of warfarin dose with genes involved in its action and metabolism
Mia Wadelius et al.
HUMAN GENETICS (2007)
siRNA silencing of calumenin enhances functional factor IX production
Nadeem Wajih et al.
BLOOD (2006)
Polymorphisms in vitamin K-dependent γ-carboxylation-related genes influence interindividual variability in plasma protein C and protein S activities in the general population
Rina Kimura et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization
Dan E. Arking et al.
NATURE GENETICS (2006)
Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal
A Oden et al.
THROMBOSIS RESEARCH (2006)
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
MJ Rieder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9
C Jonathan et al.
NATURE GENETICS (2005)
Haploview: analysis and visualization of LD and haplotype maps
JC Barrett et al.
BIOINFORMATICS (2005)
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
S Rost et al.
NATURE (2004)
Two-stage designs for gene-disease association studies with sample size constraints
JM Satagopan et al.
BIOMETRICS (2004)
Multiple rare Alleles contribute to low plasma levels of HDL cholesterol
JC Cohen et al.
SCIENCE (2004)
The inhibitory effect of calumenin on the vitamin K-dependent γ-carboxylation system -: Characterization of the system in normal and warfarin-resistant rats
N Wajih et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Efficient high-throughput resequencing of genomic DNA
RD Miller et al.
GENOME RESEARCH (2003)
分享论文
